Gynecologic issues in geriatric women

Journal of Women's Health

Volumn 21, Issue 1, 2012, Pages 4-9

  Stiles, Melissa ^a   Redmer, Jackie ^a   Paddock, Elizabeth ^a   Schrager, Sarina ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; ESTRADIOL; ESTRADIOL ACETATE;

ARTICLE; CANCER SCREENING; GYNECOLOGIC DISEASE; HORMONAL THERAPY; HUMAN; LICHEN SCLEROSUS ET ATROPHICUS; MENOPAUSE; PAPANICOLAOU TEST; PELVIC ORGAN PROLAPSE; POSTMENOPAUSE; PRIORITY JOURNAL; VAGINITIS;

AGED; AGED, 80 AND OVER; FEMALE; GENITAL DISEASES, FEMALE; GERIATRIC ASSESSMENT; HEALTH SERVICES ACCESSIBILITY; HEALTH SERVICES FOR THE AGED; HEALTH STATUS; HUMANS; MASS SCREENING; POSTMENOPAUSE; UNITED STATES; WOMEN'S HEALTH; WOMEN'S HEALTH SERVICES;

EID: 84855815200     PISSN: 15409996     EISSN: 1931843X     Source Type: Journal    
DOI: 10.1089/jwh.2011.2803     Document Type: Article

References (44)

1. Department of Health and Human Services Administration on Aging. Aging statistics. Available at www.aoa.gov/aoa root/aging-statistics/index.aspx Accessed February 1, 2011.
2. Mac Bride MB, Rhodes DJ, Shuster LT. Vulvovaginal atrophy. Mayo Clin Proc. 2010;85:87-94.
3. Dennerstein L, Dudley E, Hopper JL, Guthrie JR, Burger HG. A prospective population-based study of menopausal symptoms. Obst Gynecol 2000;96:351-358.
4. Stitka CS. Atrophic vaginitis. Dermatol Ther 2010;23:514-522.
5. Castelo-Branco C, Cancelo MJ, Villero J, Nohales F, Julia MD. Management of postmenopausal vaginal atrophy and atrophic vaginitis. Maturitas 2005;52 (Suppl 1):S46-S52. (Pubitemid 41630619)
6. Oriba HA, Elsner P, Maibach HI. Vulvar physiology. Semin Dermatol 1989;8:2-6.
7. Oriba HA, Maibach HI. Vulvar transepidermal water loss (TEWL) decay curves. Effect of occlusion, delipidation, and age. Acta Derm Venereol 1989;69:461-465. (Pubitemid 20000545)
8. Semmens JP, Wagner G. Estrogen deprivation and vaginal function in postmenopausal women. JAMA 1982;248:445-448. (Pubitemid 12081750)
9. Roy S, Caillouette JC, Roy T, Faden JS. Vaginal pH is similar to follicle-stimulating hormone for menopause diagnosis. Am J Obstet Gynecol 2004;190:1272-1277. (Pubitemid 38692208)
10. Bachmann GA, Nevadunsky NS. Diagnosis and treatment of atrophic vaginitis. Am Fam Physician. 2000;61:3090-3096. (Pubitemid 30347020)
11. Suckling J, Kennedy R, Lethaby A. Local oestrogens for vaginal atrophy in postmenopausal women. Cochrane Database Syst Rev 2006;4:CD001500.
12. North American Menopause Society. The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of The North American Menopause Society. Menopause 2007;14:355.
13. Hallopeau H. Du lichen plan et particulierement de sa forme atrophique: Lichen plan scléreux: Ann Dermatol Syphiligr (Paris) 1887;8:790-791.
14. Meyrick T, Ridley CM, McGibbon DH, Black MM. Lichen sclerosus et atrophicus and autoimmunity: A study of 350 women. Br J Dermatol 1988;118:41-46.
15. De Vito JR, Merogi AJ, Vo T, et al. Role of Borrelia burgdorferi in the pathogenesis of morphoea/scleroderma and lichen sclerosus et atrophicus: A PCR study of thirty-five cases. Br J Dermatol 2000;142:481-484.
16. Fujiwara H, Fujiwara K, Hashimoto K, et al. Detection of Borrelia burgdorferi DNA (B. garinii or B. afzelii) in morphoea and lichen sclerosus et atrophicus tissue of German and Japanese but not US patients. Arch Dermatol 1997;133:41-44. (Pubitemid 27044304)
17. Carlson JA, Ambros R, Malfetano J, et al. Vulvar lichen sclerosus and squamous cell carcinoma: A cohort, case control, and investigational study with historical perspective: Implications for chronic inflammation and sclerosis the development of neoplasia. Hum Pathol 1998;29:932-948. (Pubitemid 28422041)
18. Murphy R. Lichen sclerosus. Dermatol Clin 2010;28:707-715.
19. Funaro D. Lichen sclerosus: A review and practical approach. Dermatol Ther 2004;17:28.
20. Chi CC, Baldo M, Kirtschig G, Brackenbury F, Lewis F, Wojnarowska F. Topical interventions for genital lichen sclerosus (Protocol). Cochrane Database of Systematic Reviews 2010; Issue 1: Art. No. CD008240.
21. Neill SM, Tatnall, FM, Cox NH. Guidelines for the management of lichen sclerosus. Br J Dermatol 2002:147:640-649. (Pubitemid 35286146)
22. Mazdisnian F, Degregorio F, Palmieri A. Intralesional injection of triamcinolone in the treatment of lichen sclerosus. J Reprod Med 1999;44:332-334.
23. Jones R, Scurry J, Neill S, MacLean AB. Guidelines for the follow-up of women with vulvar lichen sclerosus in specialist clinics. Am J Obstet Gynecol 2008; 198: 496.e1-496.e3.
24. Nygaard I, Barber MD, Burgio KL, et al. Prevalence of symptomatic pelvic floor disorders in women. JAMA 2008;300:1311-1316.
25. Luber KM, Boero S, Choe JY. The demographics of pelvic floor disorders: Current observations and future projections. Am J Obstet Gynecol 2001;184:1496-1501.
26. McNevin S. Overview of pelvic floor disorders. Surg Clin North Am 2010;90:195-205.
27. Sung VW, Hampton BS. Epidemiology of pelvic floor dysfunction. Obstet Gynecol Clin North Am. 2009;36:421-443.
28. Ellerkmann RM, Cundiff GW, Mellick CF, Nihara MA, Leffler K, Bent AE. Correlation of symptoms with location and severity of pelvic organ prolapse. Am J Obstet Gynecol 2001;185:1332-1337.
29. Hagen S, Stark D, Maher C, Adams E. Conservative management of pelvic organ prolapse in women. Cochrane Database Syst Rev 2006;4:CD003882
30. American College of Obstetricians and Gynecologists. Pelvic organ prolapse. Washington, DC: ACOG; 2007.
31. Astrup K. Frequency of spontaneously occurring postmenopausal bleeding in the general population. Acta Obstst Gynecol Scand 2004;83:203-207. (Pubitemid 38234059)
32. Hale GE, Fraser I S. Changes in the menstrual pattern during the menopause transition. In: Lobo RA, ed.: Treatment of the postmenopausal woman: Basic and clinical aspects, 3rd ed. Burlington, MA: Elsevier, 2007.
33. American Cancer Society. Cancer facts and figures 2010. Available at www.cancer.org/acs/groups/content/@epi demiologysurveilance/documents/document/ acspc-026238 .pdf Accessed December 7, 2010.
34. Tabor A, Watt HC, Wald NJ. Endometrial thickness as a test for endometrial cancer in women with postmenopausal vaginal bleeding. Obstet Gynecol 2002;99:663-670. (Pubitemid 34246309)
35. Goldstein SR. The role of transvaginal ultrasound or endometrial biopsy in the evaluation of the menopausal endometrium. Am J Obstet Gynecol 2009;201:5-11.
36. Timmermans A, Opmeer BC, Khan KS, et al. Endometrial thickness measurement for detecting endometrial cancer in women with postmenopausal bleeding: A systematic review and meta-analsysis. Obstet Gynecol 2010;116:160-167.
37. Dijkhuizen FP, Mol BW, Brolmann HA, et al. The accuracy of endometrial sampling in the diagnosis of patients with endometrial carcinoma and hyperplasia: A meta-analysis. Cancer 2000;89:1765-1772.
38. Spicer JM, Siebert K, Kruger TF. Postmenopausal bleeding: A diagnostic approach for both private and public sectors. Gynecol Obstet Invest 2006;61:174-178.
39. American College of Obstetricians and Gynecologists. Practice bulletin No. 109: Cervical cytology screening. Obstet Gynecol 2009;114:1409-1420.
40. U.S. Preventive Service Task Force. Screening for ovarian cancer, 2004. Available at www.uspreventiveservicestaskforce .org/3rduspstf/ovariancan/ ovcanrs.htm Accessed January 21, 2011.
41. Westhoff CL, Jones HE, Guiahi M. Do new guidelines and technology make the routine pelvic examination obsolete? J Womens Health 2011;20:5-10.
42. Murray J. Geriatric gynecology. In: Gallo JJ, Busby-Whitehead J, Rabins PV, Stillman RA, Murphy JB, Reichel W, eds. Reichels care of the elderly: Clinical aspects of aging. Philadelphia: Lippincott Williams & Wilbins 1999:392-406.
43. American College of Obstetricians and Gynecologists. Practice bulletin No. 431: Routine pelvic examination and cervical cytology screening. Obstet Gynecol 2009;113:1190-1193.
44. Stewart R, Thistlethwaite J, Evans R. Pelvic examination of asymptomatic woman. Aust Fam Physician 2008;37: 493-496.